scholarly journals Prunella vulgaris L. Potentiates Answer to the Emergence of Dreaded Antibiotic Resistance

Author(s):  
Jitendra K. Patel ◽  
Chetan Kumar Joshi ◽  
Mukesh Kumar Sharma

Medicinal herbs that are in use for centuries to treat infections and other illnesses. Prunella vulgaris L. is traditionally used for its therapeutic attributes for the alleviation of various infectious diseases. The objective of this study on Prunella vulgaris was to reveal relevant pharmaceutical information to understand its beneficial medicinal uses for human beings. The methanolic and petroleum ether extracts after removal of the solvent under reduced pressure from the Prunella vulgaris plants were prepared and these extracts were analyzed in vitro for their activity against B. subtilis, E. coli, S. aureus and S. typhi (with ATCC numbers 6051, 25922, 23235 and 14028 respectively). Likewise, in vivo studies were conducted using the E. coli-induced peritonitis in laboratory rat models where the rats were given allopathic antibiotic ofloxacin and the results were compared with those rats who received plant extracts under controlled conditions. The results were analyzed for the efficacy of the plant extracts was compared with ofloxacin; the methanol extracts exhibited equally if not better results in clearing the pathogen from the system of animals. The petroleum ether extracts exhibited the least antimicrobial activity in comparison to those extracted in methanol isolates. In conclusion, the herbal extract demonstrated significant antibacterial activity both under in-vitro and in-vivo studies which is a major outcome of the study. During this study, all standards and norms were followed as per government animal authority.

Nutrients ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 2223
Author(s):  
Manon Dominique ◽  
Nicolas Lucas ◽  
Romain Legrand ◽  
Illona-Marie Bouleté ◽  
Christine Bôle-Feysot ◽  
...  

CLPB (Caseinolytic peptidase B) protein is a conformational mimetic of α-MSH, an anorectic hormone. Previous in vivo studies have already shown the potential effect of CLPB protein on food intake and on the production of peptide YY (PYY) by injection of E. coli wild type (WT) or E. coli ΔClpB. However, until now, no study has shown its direct effect on food intake. Furthermore, this protein can fragment naturally. Therefore, the aim of this study was (i) to evaluate the in vitro effects of CLPB fragments on PYY production; and (ii) to test the in vivo effects of a CLPB fragment sharing molecular mimicry with α-MSH (CLPB25) compared to natural fragments of the CLPB protein (CLPB96). To do that, a primary culture of intestinal mucosal cells from male Sprague–Dawley rats was incubated with proteins extracted from E. coli WT and ΔCLPB after fragmentation with trypsin or after a heat treatment of the CLPB protein. PYY secretion was measured by ELISA. CLPB fragments were analyzed by Western Blot using anti-α-MSH antibodies. In vivo effects of the CLPB protein on food intake were evaluated by intraperitoneal injections in male C57Bl/6 and ob/ob mice using the BioDAQ® system. The natural CLPB96 fragmentation increased PYY production in vitro and significantly decreased cumulative food intake from 2 h in C57Bl/6 and ob/ob mice on the contrary to CLPB25. Therefore, the anorexigenic effect of CLPB is likely the consequence of enhanced PYY secretion.


2021 ◽  
Vol 8 (01) ◽  
Author(s):  
KAMLESH RAM ◽  
RAMESH SINGH

In Vitro and In Vivo studies on the efficacy of fungicides and biopesticides. Among the fungicides, in Carbedazim to the most effective as they have inhibited the mycelia growth completely of the test fungus, and Benomyl, Topsin - M, Ridomil,Vitavax were found the next best in inhibiting the mycelial growth of the pathogen up to 92.11% to 83.46% respectively. Sadabahar was least effective plant extracts which causes 42 mm of radial growth and inhibited the growth of the only 19.23%. In Vivo condition the maximum seed germination (95.50% and 95.33%), minimum wilt incidence (5.16% and 3.65%) and highest grain yield (10.50 q/ha and 10.35 q/ha) was found seed treatment with Carbendazim (0.2%). Among the test plant extracts Tulsi was lested effective, which show the minimum seed germination (80.00% and 77.50%), maximum wilt incidence (15.70% and 14.10%), and lowest grain yield (3.92 q/ha and 4.17 q/ha).


2020 ◽  
Vol 14 (6) ◽  
pp. 147-155
Author(s):  
J. N. Agbom ◽  
O. Ogbu ◽  
I. R. Iroha ◽  
I. B. Moses ◽  
A. L. Onuora ◽  
...  

1997 ◽  
Vol 41 (1) ◽  
pp. 49-53 ◽  
Author(s):  
A Ahmed ◽  
M M París ◽  
M Trujillo ◽  
S M Hickey ◽  
L Wubbel ◽  
...  

In vitro and in vivo studies have demonstrated that the bacteriologic efficacy of once-daily aminoglycoside therapy is equivalent to that achieved with conventional multiple daily dosing. The impact of once-daily dosing for meningitis has not been studied. Using the well-characterized rabbit meningitis model, we compared two regimens of the same daily dosage of gentamicin given either once or in three divided doses for 24 or 72 h. The initial 1 h mean cerebrospinal fluid (CSF) gentamicin concentration for animals receiving a single dose (2.9 +/- 1.7 micrograms/ml) was threefold higher than that for the animals receiving multiple doses. The rate of bacterial killing in the first 8 h of treatment was significantly greater for the animals with higher concentrations in their CSF (-0.21 +/- 0.19 versus -0.03 +/- 0.22 log10 CFU/ml/h), suggesting concentration-dependent killing. By 24h, the mean reduction in bacterial titers was similar for the two regimens. In animals treated for 72 h, no differences in bactericidal activity was noted for 24, 48, or 72 h. Gentamicin at two different dosages was administered intracisternally to a separate set of animals to achieve considerably higher CSF gentamicin concentrations. In these animals, the rate of bacterial clearance in the first 8 h (0.52 +/- 0.15 and 0.58 +/- 0.15 log10 CFU/ml/h for the lower and higher dosages, respectively) was significantly greater than that in animals treated intravenously. In conclusion, there is evidence of concentration-dependent killing with gentamicin early in treatment for experimental E. coli meningitis, and once-daily dosing therapy appears to be at least as effective as multiple-dose therapy in reducing bacterial counts in CSF.


1970 ◽  
Vol 2 (2) ◽  
pp. 99-102 ◽  
Author(s):  
MA Rahman ◽  
MA Samad ◽  
MB Rahman ◽  
SML Kabir

Avian salmonellosis (AS), avian colibacillosis (AC) and avian pasteurellosis (AP) have been recognized as important bacterial diseases in poultry associated with morbidity and mortality in Bangladesh. The causative agents of these three diseases were isolated (5 isolates / disease) from dead chickens submitted for diagnosis at the BRAC Poultry Disease Diagnostic Centre, Gazipur during the period from January to December 2002. Five isolates of each of the Salmonella pullorum, Escherichia coli and Pasteurella multocida were evaluated against eight antibiotic containing disc which included ciprofloxacin, gentamicin, ampicillin, chloramphenicol, erythromycin, tetracycline, cephradine and penicillin G. Erythromycin in S. pullorum and Ciprofloxacin both in the E. coli and P. multocida were found highest sensitive, gentamicin, chloramphenicol, cephradine were found moderately sensitive to S. pullorum, gentamicin, tetracycline, erythromycin and ampicillin were found moderately sensitive to E. coli, and gentamicin ampicillin, cephradine and penicillin G were moderately sensitive to P. multocida. Therapeutic trials against experimentally produced S. pullorum, E. coli and P. multocida infection in three groups of broiler chickens showed that cephradine against S. pullorum and ciprofloxacin against both in E. coli and P. multocida were found highly effective both in vitro and in vivo studies, therefore, cephradine against salmonellosis and ciprofloxacin against colibacillosis and pasteurellosis are effective drugs of choice which could be used to control morbidity and mortality in poultry caused by these diseases.Key words: antibiotic sensitivity; salmonellosis; colibacillosis; pasteurellosis, broiler chickensdoi: 10.3329/bjvm.v2i2.2538Bangl. J. Vet. Med. (2004). 2 (2): 99-102


2005 ◽  
Vol 73 (11) ◽  
pp. 7597-7601 ◽  
Author(s):  
K. Wroblewska-Seniuk ◽  
R. Selvarangan ◽  
A. Hart ◽  
R. Pladzyk ◽  
P. Goluszko ◽  
...  

ABSTRACT Escherichia coli bearing adhesins of the Dr/Afa family frequently causes urogenital infections during pregnancy in humans and has been associated with mortality in pregnant rats. Two components of the adhesin, Dra/AfaE and Dra/AfaD, considered virulence factors, are responsible for bacterial binding and internalization. We hypothesize that gestational mortality caused by Dr/Afa+ E. coli is mediated by one of these two proteins, Dra/AfaE or Dra/AfaD. In this study, using afaE and/or afaD mutants, we investigated the role of the afaE and afaD genes in the mortality of pregnant rats from intrauterine infection. Sprague-Dawley rats, on the 17th day of pregnancy, were infected with the E. coli afaE + afaD and afaE afaD + mutants. The clinical E. coli strain (afaE + afaD +) and the afaE afaD double mutant were used as positive and negative controls, respectively. The mortality rate was evaluated 24 h after infection. The highest maternal mortality was observed in the group infected with the afaE + afaD + strain, followed by the group infected with the afaE + afaD strain. The mortality was dose dependent. The afaE afaD double mutant did not cause maternal mortality, even with the highest infection dose. The in vivo studies corresponded with the invasion assay, where the afaE + strains were the most invasive (afaE + afaD strain > afaE + afaD + strain), while the afaE mutant strains (afaE afaD + and afaE afaD strains) seemed to be noninvasive. This study shows for the first time that the afaE gene coding for the AfaE subunit of Dr/Afa adhesin is involved in the lethal outcome of gestational infection in rats. This lethal effect associated with AfaE correlates with the invasiveness of afaE + E. coli strains in vitro.


2008 ◽  
Vol 1784 (11) ◽  
pp. 1652-1658 ◽  
Author(s):  
Dominique Guianvarc'h ◽  
Guangqi E ◽  
Thierry Drujon ◽  
Camille Rey ◽  
Qian Wang ◽  
...  

2018 ◽  
Vol 44 (1) ◽  
pp. 6
Author(s):  
Ljiljana Suvajdžić ◽  
Slobodan Gigov ◽  
Aleksandar Rašković ◽  
Srđan Stojanović ◽  
Maja Bekut ◽  
...  

Background: Multiple resistances to antibiotics are an emergent problem worldwide. Scientists intensively search for new substances with the antimicrobial potential or the mode to restore the activity of old-generation antibiotics. Ampicillin is the antibiotic with the expanded range of antimicrobial activity, but its use has decreased due to the poor absorption and highly developed resistance. In vivo studies showed that ampicillin has better absorption and bioavailability if combined with bile acid salts. The aim of this study was to examine antimicrobial effects of ampicillin alone and its combination with semisynthetic monoketocholic acid salt (MKH) in vitro.Materials, Methods & Results: In this study, commercial preparation of ampicillin and sodium salt of 3α,7α-dihydroxy-12oxo-5β-cholanate were used. Their effects were evaluated on Escherichia coli (E. coli), Enterococcus faecalis (E. faecalis) and Enterococcus faecium (E. faecium), obtained from urine specimens of dogs with clinically manifested cystitis. The first two investigated strains were ampicillin-sensitive, while E. faecium was resistant to ampicillin. Modified macrodilution method according to Clinical and Laboratory Standards Institute Guidelines (M7-A8) was performed. Bacterial suspension equivalent to 0.5 McFarland was prepared in saline, compared to the standard (Biomerieux) ad oculi. The density was checked spectrophotometrically at a wavelength of 625 nm and adjusted if necessary to the desired absorbance from 0.08 to 0.1. The resultant suspension was diluted 1:100 and inoculated in test tubes. Number of bacteria was counted on Petri plates using dilutions from 10-3 to 10-7 in order to obtain valid and countable plates. One hundred microliters of appropriate dilutions were aseptically plated in triplicate onto nutrient agar. Plates were incubated on 37°C for 72 h, under aerobic conditions. The number of colony forming units (CFU) was determined by direct counting. As a valid for enumeration, we took plates with 30 to 300 CFU. Percentage of killed bacteria for ampicillin was from 69.33-95.19% for E. coli, 87.1296.92% for E. faecalis and 7.20-33.30% for E. faecium. Ampicillin applied in the combination with MKH killed 99.99% to 100% of E. coli, 94.59% to 99.91% of E. faecalis and 31.73% to 64.76% of E. faecium. Mean percentage of killed bacteria for ampicillin was 81.93% for E. coli, 91.64% for E. faecalis, and 18.13% for E. faecium, while in combination with MKH percentage was 99.96% for E. coli, 98.23% for E. faecalis and 47.54% for E. faecium.Discussion: Results are presented as pharmacological minimal inhibitory concentration (MIC) values. Ampicillin was applied at the concentration higher than the therapeutic one, which could explain high MIC values for E. coli and E. faecalis. The combination of ampicillin with MKH showed the best improvement of antimicrobial effect on E. faecium (Δ = 29.41%), isolate that was resistant to ampicillin when applied alone. In all the investigated isolates, the combinations with MKH were more effective than ampicillin administered alone. It seems that MKH demonstrates a synergistic antimicrobial activity with ampicillin in vitro, which considerably decreases MIC values for all investigated isolates. These results implicate that MKH could restore the previous activity of ampicillin against some bacteria, which could be a significant benefit for clinical practice.


2018 ◽  
pp. 31-38

Actividad antibacteriana de extractos vegetales frente a cepas intrahospitalarias, Iquitos-Perú Antibacterial activity of plant extracts against nosocomial strains, Iquitos-Peru Ricardo E. Abadie, Ronald Medina O., Lastenia Ruiz, Alvaro Tresierra-Ayala Laboratorio de Microbiología. Centro de Investigación de Recursos Naturales de la Universidad Nacional de la Amazonía Peruana (CIRNA-UNAP). Psje. Los Paujiles S/N, San Lorenzo, distrito de San Juan Bautista, Iquitos-Perú DOI: https://doi.org/10.33017/RevECIPeru2014.0005/  Resumen La región amazónica es una de las áreas que posee la mayor biodiversidad del mundo, albergando varios miles de especies de plantas, muchas de las cuales son utilizadas por sus pobladores como plantas medicinales. Durante los últimos años, el empleo de estos recursos vegetales o de sus productos viene incrementándose de manera importante, lo cual podría deberse a una serie de factores, entre los que destacan el conocimiento de su composición química, y al hecho que en la actualidad se han realizado numerosos ensayos farmacológicos tanto in vivo como in vitro. La aparición de cepas resistentes a los antibióticos comerciales en los últimos tiempos, está creando la necesidad de buscar otras estrategias o alternativas para controlarlas, tal es el caso del uso de las plantas (medicina tradicional), debido a los principios activos que poseen. Se pretende con este trabajo, determinar probables alternativas para combatir infecciones bacterianas de aquellos agentes drogoresistentes, este problema reviste importancia crítica particular en los países en desarrollo, donde quizás no se dispone de antibióticos de segunda línea más costosos o, si los hay, su precio es inasequible. El estudio se realizó en la ciudad de Iquitos, Provincia de Maynas, Departamento de Loreto. Los ensayos microbiológicos se realizaron en el Laboratorio de Microbiología del Centro de Investigación de Recursos Naturales de la Amazonia (CIRNA) de la Universidad Nacional de la Amazonia  Peruana (UNAP). Se determinó la actividad antibacteriana de 6 extractos vegetales (Alchornea triplinervia, Annona muricata, Averrhoa carambola, Brunfelsia grandiflora, Caraipa grandifolia y Cedrela odorata) mediante la técnica de difusión en disco, y a aquellos que presentaron actividad se les determinó la Concentración Inhibitoria Mínima y la Concentración Bactericida Mínima mediante la técnica de macrodilución en caldo. Ninguno de los extractos tuvieron actividad frente a las cepas de E. coli; cuatro extractos tuvieron actividad frente a las cepas de P. aeruginosa, siendo los extractos de Cedrela odorata y Alchornea triplinervia los que tuvieron mayor actividad frente a esta bacteria, con CIM = 15.62 y 62.5 mg/ml, respectivamente; todos los extractos tuvieron actividad frente a las cepas de S. aureus, siendo los extracto de C. odorata, A. triplinervia y Caraipa grandiflora, los de mayor actividad con una CIM = 3.91 mg/ml para cada uno.  Se obtuvieron prometedores resultados de actividad antibacteriana de los extractos en estudio frente a cepas intrahospitalarias, mayormente contra S. aureus. Descriptores: Actividad antibacteriana, extractos vegetales, cepas intrahospitalarias Abstract The Amazon region is one of the areas with the largest biodiversity in the world, hosting several thousand species of plants, many of which are used by its people as medicinal plants. In recent years, the use of these plant resources or products has been increasing significantly, which could be due to a number of factors, among them the knowledge of their chemical composition, and the fact that at present there have been numerous pharmacological tests both in vivo and in vitro. The emergence of antibiotic-resistant strains in recent years, is creating a need for other strategies or ways to control them, as in the case of the use of plants (traditional medicine), because the active ingredients bearing. This work is intended to determine probable alternatives to combat bacterial infections of those agents antibiotic-resistant, this problem is particularly critical in developing countries, where perhaps there are no antibiotics or expensive second line, if any, price is unavailable. The study was conducted in Iquitos city, Province of Maynas, Department of Loreto. Microbiological tests were performed at Microbiology Laboratory of Research Center of Natural Resources of the Amazon (CIRNA) of the National University of the Peruvian Amazon (UNAP). The antibacterial activity of six plant extracts (Alchornea triplinervia, Annona muricata, Averrhoa carambola, Brunfelsia grandiflora, Caraipa grandifolia y Cedrela odorata) by the disk diffusion method was determined, and those that showed activity were determined Minimum Inhibitory Concentration and Minimum Bactericidal Concentration by macrodilution technique. None of the extracts were active against strains of E. coli; four extracts had activity against strains of P. aeruginosa, with Cedrela odorata and Alchornea triplinervia extracts which had greater activity against these bacteria, with MIC = 15.62 and 62.5 mg/ml, respectively; all extracts were active against strains of S. aureus, with the extract of C. odorata, A. triplinervia and Caraipa grandiflora, the most active with an MIC = 3.91 mg/ml for each. Was obtained Promising results of antibacterial activity of the extracts in study against nosocomial strains, mostly against S. aureus. Keywords: Antibacterial activity, plant extracts, nosocomial strains


2020 ◽  
Vol 117 (38) ◽  
pp. 23794-23801
Author(s):  
Zhe Hu ◽  
John E. Cronan

Biotin plays an essential role in growth of mycobacteria. Synthesis of the cofactor is essential forMycobacterium tuberculosisto establish and maintain chronic infections in a murine model of tuberculosis. Although the late steps of mycobacterial biotin synthesis, assembly of the heterocyclic rings, are thought to follow the canonical pathway, the mechanism of synthesis of the pimelic acid moiety that contributes most of the biotin carbon atoms is unknown. We report that theMycobacterium smegmatisgene annotated as encoding Tam, anO-methyltransferase that monomethylates and detoxifiestrans-aconitate, instead encodes a protein having the activity of BioC, anO-methyltransferase that methylates the free carboxyl of malonyl-ACP. TheM. smegmatisTam functionally replacedEscherichia coliBioC both in vivo and in vitro. Moreover, deletion of theM. smegmatis tamgene resulted in biotin auxotrophy, and addition of biotin toM. smegmatiscultures repressedtamgene transcription. Although its pathogenicity precluded in vivo studies, theM. tuberculosisTam also replacedE. coliBioC both in vivo and in vitro and complemented biotin-independent growth of theM. smegmatis tamdeletion mutant strain. Based on these data, we propose that the highly conserved mycobacterial tamgenes be renamedbioC.M. tuberculosisBioC presents a target for antituberculosis drugs which thus far have been directed at late reactions in the pathway with some success.


Sign in / Sign up

Export Citation Format

Share Document